Osaic Holdings
STRO icon

Osaic Holdings’s Sutro Biopharma STRO Stock Holding History

Osaic Holdings’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32K Sell
100
-1,180
-92% -$36.8K ﹤0.01% 7098
2026
Q1 		$31.9K Sell
1,280
-58
-4% -$1.05K ﹤0.01% 5538
2025
Q4 		$15.5K Sell
1,338
-777
-37% -$7.37K ﹤0.01% 6030
2025
Q3 		$18K Hold
2,115
– – ﹤0.01% 6003
2025
Q2 		$15K Sell
2,115
-185
-8% -$1.51K ﹤0.01% 5909
2025
Q1 		$14.9K Buy
2,300
+346
+18% +$5.45K ﹤0.01% 5558
2024
Q4 		$35.9K Buy
1,954
+899
+85% +$27.4K ﹤0.01% 4929
2024
Q3 		$36.5K Sell
1,055
-129
-11% -$5.06K ﹤0.01% 4961
2024
Q2 		$34.7K Buy
1,184
+99
+9% +$3.92K ﹤0.01% 4961
2024
Q1 		$61.3K Buy
1,085
+60
+6% +$2.65K ﹤0.01% 4596
2023
Q4 		$44K Hold
1,025
– – ﹤0.01% 4989
2023
Q3 		$35.6K Buy
1,025
+25
+3% +$1.09K ﹤0.01% 5219
2023
Q2 		$46.5K Hold
1,000
– – ﹤0.01% 4986
2023
Q1 		$46.2K Buy
1,000
+50
+5% +$3.17K ﹤0.01% 5011
2022
Q4 		$76.8K Buy
+950
New +$66K ﹤0.01% 4642
2021
Q1 		– Sell
-20
Closed -$4K – 6942
2020
Q4 		$4K Hold
20
– – ﹤0.01% 5880
2020
Q3 		$2K Hold
20
– – ﹤0.01% 5894
2020
Q2 		$2K Hold
20
– – ﹤0.01% 5829
2020
Q1 		$2K Buy
+20
New +$2.1K ﹤0.01% 5730

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Osaic Holdings's STRO Position: Q2 2026 in Review

Osaic Holdings reduced its Sutro Biopharma (STRO) stake by 92% in Q2 2026, selling an estimated $36.8K and leaving 100 shares worth $3.32K. The position accounts for ﹤0.01% of the portfolio, ranked #7098.

Osaic Holdings first reported a position in STRO in Q1 2020 and has held it in 19 quarters since. The position peaked at $76.8K in Q4 2022. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Osaic Holdings held 100 shares of Sutro Biopharma worth $3.32K as of Q2 2026.
  • Osaic Holdings sold 1,180 Sutro Biopharma shares in Q2 2026, an estimated $36.8K.
  • Sutro Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7098 holding.
  • Osaic Holdings first reported a position in Sutro Biopharma in Q1 2020 and has held it in 19 quarters since.
  • Osaic Holdings's Sutro Biopharma position peaked at $76.8K in Q4 2022.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.